Annual EBITDA
-$8.63 M
+$2.21 M+20.37%
01 December 2023
Summary:
Revelation Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$8.63 million, with the most recent change of +$2.21 million (+20.37%) on 01 December 2023. REVB annual EBITDA is now -110.59% below its all-time high of $81.52 million, reached on 01 December 2019.REVB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$1.79 M
+$725.70 K+28.85%
01 September 2024
Summary:
Revelation Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$1.79 million, with the most recent change of +$725.70 thousand (+28.85%) on 01 September 2024. Over the past year, it has increased by +$530.10 thousand (+22.85%). REVB quarterly EBITDA is now -49.97% below its all-time high of -$1.19 million, reached on 30 September 2022.REVB Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$8.52 M
+$982.10 K+10.34%
01 September 2024
Summary:
Revelation Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$8.52 million, with the most recent change of +$982.10 thousand (+10.34%) on 01 September 2024. Over the past year, it has increased by +$111.40 thousand (+1.29%). REVB TTM EBITDA is now -226.81% below its all-time high of -$2.61 million, reached on 31 March 2021.REVB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
REVB EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +22.9% | +1.3% |
| 3 y3 years | - | +41.1% | -5.4% |
| 5 y5 years | -110.6% | - | - |
REVB EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.7% | -50.0% | +72.8% | -45.1% | +46.4% |
| 5 y | 5 years | -110.6% | +27.7% | -50.0% | +72.8% | -226.8% | +46.4% |
| alltime | all time | -110.6% | +27.7% | -50.0% | +72.8% | -226.8% | +46.4% |
Revelation Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.79 M(-28.9%) | -$8.52 M(-10.3%) |
| June 2024 | - | -$2.52 M(+32.7%) | -$9.50 M(+6.6%) |
| Mar 2024 | - | -$1.90 M(-18.3%) | -$8.91 M(+3.3%) |
| Dec 2023 | -$8.63 M(-20.4%) | -$2.32 M(-16.3%) | -$8.63 M(+14.7%) |
| Sept 2023 | - | -$2.77 M(+43.8%) | -$7.52 M(+26.5%) |
| June 2023 | - | -$1.93 M(+19.4%) | -$5.95 M(+1.2%) |
| Mar 2023 | - | -$1.61 M(+33.1%) | -$5.87 M(-45.8%) |
| Dec 2022 | -$10.84 M | -$1.21 M(+1.6%) | -$10.84 M(-19.6%) |
| Sept 2022 | - | -$1.19 M(-35.6%) | -$13.48 M(-12.0%) |
| June 2022 | - | -$1.85 M(-71.8%) | -$15.32 M(-3.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$6.58 M(+70.9%) | -$15.91 M(+33.3%) |
| Dec 2021 | -$11.93 M(-114.6%) | -$3.85 M(+26.8%) | -$11.93 M(+47.6%) |
| Sept 2021 | - | -$3.04 M(+24.6%) | -$8.08 M(+60.2%) |
| June 2021 | - | -$2.44 M(-6.5%) | -$5.05 M(+93.5%) |
| Mar 2021 | - | -$2.61 M | -$2.61 M |
| Dec 2019 | $81.52 M(+30.1%) | - | - |
| Dec 2018 | $62.67 M(+30.6%) | - | - |
| Dec 2017 | $48.00 M(+88.7%) | - | - |
| Dec 2016 | $25.44 M(+61.8%) | - | - |
| Dec 2015 | $15.72 M | - | - |
FAQ
- What is Revelation Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Revelation Biosciences?
- What is Revelation Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Revelation Biosciences?
- What is Revelation Biosciences quarterly EBITDA year-on-year change?
- What is Revelation Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Revelation Biosciences?
- What is Revelation Biosciences TTM EBITDA year-on-year change?
What is Revelation Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of REVB is -$8.63 M
What is the all time high annual EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is $81.52 M
What is Revelation Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of REVB is -$1.79 M
What is the all time high quarterly EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$1.19 M
What is Revelation Biosciences quarterly EBITDA year-on-year change?
Over the past year, REVB quarterly earnings before interest, taxes, depreciation & amortization has changed by +$530.10 K (+22.85%)
What is Revelation Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of REVB is -$8.52 M
What is the all time high TTM EBITDA for Revelation Biosciences?
Revelation Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$2.61 M
What is Revelation Biosciences TTM EBITDA year-on-year change?
Over the past year, REVB TTM earnings before interest, taxes, depreciation & amortization has changed by +$111.40 K (+1.29%)